🇺🇸 FDA
Company

Iterum

Iterum Therapeutics plc

ITRMF pharma USA

Quick answer

Iterum is a pharma company (ITRMF) headquartered in DUBLIN 1, L2, USA with 8 tracked pipeline programs.

Pipeline (8)

project

Azithromycin plus hydroxychloroquine

Respiratory Tract Infection Viral

Phase 3 · small_molecule · terminated

1 trials project

Ertapenem

Intra Abdominal Infections

Phase 3 · small_molecule · completed

1 trials project

Sulopenem

Complicated Urinary Tract Infections

Phase 3 · small_molecule · completed

1 trials project

Sulopenem etzadroxil/probenecid

Urinary Tract Infections

Phase 3 · small_molecule · completed

1 trials project

Sulopenem-Etzadroxil/Probenecid

Uncomplicated Urinary Tract Infections

Phase 3 · small_molecule · completed

1 trials project

Sulopenem

Urinary Tract Infections

Phase 1 · small_molecule · terminated

1 trials project

sulopenem etzadroxil and probenecid

Pharmacokinetics After Oral Intake

Phase 1 · small_molecule · active

1 trials project

Ciprofloxacin

UTI - Lower Urinary Tract Infection

Approved · small_molecule · completed

1 trials

Patents (3)

patent

US 12128034

Combinations of beta-lactam compounds, probenecid, and valproic acid and uses th

Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12109197

Combinations of β-lactam compounds and probenecid and uses thereof

Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11478428

Combinations of beta-lactam compounds and probenecid and uses thereof

Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)